Histogram
Visit (Number) vs AM Systolic Blood Presure 2nd Measurement
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | 1,504 | 116.1 | ± 32.3 | 120.0 | -2.0 | 238.0 | 12 | 1,516 |
Diagnostic Visit (DX) | 1,232 | 122.1 | ± 19.9 | 122.0 | -3.0 | 190.0 | 284 | 1,516 |
CPAP Titration Visit (CPAP) | 1,056 | 118.0 | ± 28.0 | 122.0 | -3.0 | 192.0 | 460 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 122.0 | ± 17.2 | 122.0 | -2.0 | 196.0 | 637 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 102.4 | ± 47.4 | 120.0 | -2.0 | 172.0 | 683 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 121.3 | ± 17.9 | 120.0 | -2.0 | 198.0 | 665 | 1,516 |
Gender vs AM Systolic Blood Presure 2nd Measurement
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs AM Systolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,504 | 116.1 | ± 32.3 | 120.0 | -2.0 | 238.0 | 12 | 1,516 |
Male | 950 | 116.4 | ± 33.6 | 122.0 | -2.0 | 238.0 | 8 | 958 |
Female | 554 | 115.6 | ± 29.8 | 120.0 | -2.0 | 186.0 | 4 | 558 |
Gender vs AM Systolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,232 | 122.1 | ± 19.9 | 122.0 | -3.0 | 190.0 | 284 | 1,516 |
Male | 788 | 122.8 | ± 20.3 | 123.0 | -3.0 | 190.0 | 170 | 958 |
Female | 444 | 120.8 | ± 19.0 | 120.0 | -1.0 | 178.0 | 114 | 558 |
Gender vs AM Systolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,056 | 118.0 | ± 28.0 | 122.0 | -3.0 | 192.0 | 460 | 1,516 |
Male | 693 | 119.1 | ± 27.4 | 122.0 | -3.0 | 192.0 | 265 | 958 |
Female | 363 | 115.8 | ± 29.1 | 120.0 | -3.0 | 152.0 | 195 | 558 |
Gender vs AM Systolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 122.0 | ± 17.2 | 122.0 | -2.0 | 196.0 | 637 | 1,516 |
Male | 572 | 122.9 | ± 16.4 | 122.0 | -2.0 | 196.0 | 386 | 958 |
Female | 307 | 120.3 | ± 18.6 | 122.0 | -1.0 | 164.0 | 251 | 558 |
Gender vs AM Systolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 833 | 102.4 | ± 47.4 | 120.0 | -2.0 | 172.0 | 683 | 1,516 |
Male | 541 | 104.1 | ± 46.9 | 120.0 | -2.0 | 172.0 | 417 | 958 |
Female | 292 | 99.3 | ± 48.1 | 118.0 | -2.0 | 172.0 | 266 | 558 |
Gender vs AM Systolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 851 | 121.3 | ± 17.9 | 120.0 | -2.0 | 198.0 | 665 | 1,516 |
Male | 552 | 122.5 | ± 16.6 | 122.0 | -1.0 | 198.0 | 406 | 958 |
Female | 299 | 119.1 | ± 20.0 | 120.0 | -2.0 | 164.0 | 259 | 558 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,504 | 116.1 | ± 32.3 | 120.0 | -2.0 | 238.0 | 12 | 1,516 |
Native American | 27 | 118.1 | ± 29.0 | 120.0 | -2.0 | 170.0 | 1 | 28 |
Asian | 88 | 113.0 | ± 25.2 | 116.0 | -1.0 | 147.0 | 1 | 89 |
Black | 170 | 113.9 | ± 39.0 | 120.0 | -1.0 | 182.0 | 2 | 172 |
Hispanic | 114 | 116.7 | ± 26.8 | 120.0 | -1.0 | 170.0 | 2 | 116 |
White | 1,096 | 116.6 | ± 32.1 | 120.0 | -2.0 | 238.0 | 6 | 1,102 |
Other | 9 | 109.0 | ± 43.3 | 114.0 | -1.0 | 144.0 | - | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,232 | 122.1 | ± 19.9 | 122.0 | -3.0 | 190.0 | 284 | 1,516 |
Native American | 20 | 125.4 | ± 16.6 | 124.0 | 102.0 | 172.0 | 8 | 28 |
Asian | 74 | 115.1 | ± 22.7 | 118.0 | -1.0 | 150.0 | 15 | 89 |
Black | 120 | 121.5 | ± 26.5 | 124.0 | -2.0 | 178.0 | 52 | 172 |
Hispanic | 84 | 121.2 | ± 17.4 | 122.0 | -1.0 | 148.0 | 32 | 116 |
White | 926 | 122.7 | ± 18.9 | 122.0 | -3.0 | 190.0 | 176 | 1,102 |
Other | 8 | 125.4 | ± 11.2 | 123.0 | 112.0 | 146.0 | 1 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,056 | 118.0 | ± 28.0 | 122.0 | -3.0 | 192.0 | 460 | 1,516 |
Native American | 16 | 122.4 | ± 38.0 | 128.0 | -1.0 | 192.0 | 12 | 28 |
Asian | 58 | 119.7 | ± 11.1 | 119.0 | 100.0 | 146.0 | 31 | 89 |
Black | 96 | 116.0 | ± 37.2 | 122.0 | -1.0 | 152.0 | 76 | 172 |
Hispanic | 73 | 121.1 | ± 17.9 | 120.0 | -1.0 | 154.0 | 43 | 116 |
White | 808 | 117.7 | ± 28.2 | 122.0 | -3.0 | 188.0 | 294 | 1,102 |
Other | 5 | 126.0 | ± 16.9 | 128.0 | 110.0 | 152.0 | 4 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 122.0 | ± 17.2 | 122.0 | -2.0 | 196.0 | 637 | 1,516 |
Native American | 13 | 125.7 | ± 24.1 | 120.0 | 104.0 | 186.0 | 15 | 28 |
Asian | 49 | 118.3 | ± 8.8 | 118.0 | 102.0 | 140.0 | 40 | 89 |
Black | 77 | 125.2 | ± 24.3 | 128.0 | -1.0 | 196.0 | 95 | 172 |
Hispanic | 65 | 122.7 | ± 11.3 | 122.0 | 100.0 | 156.0 | 51 | 116 |
White | 672 | 121.7 | ± 17.0 | 122.0 | -2.0 | 182.0 | 430 | 1,102 |
Other | 3 | 136.7 | ± 9.9 | 132.0 | 130.0 | 148.0 | 6 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 833 | 102.4 | ± 47.4 | 120.0 | -2.0 | 172.0 | 683 | 1,516 |
Native American | 10 | 106.0 | ± 38.8 | 117.0 | -2.0 | 132.0 | 18 | 28 |
Asian | 47 | 100.4 | ± 40.6 | 110.0 | -2.0 | 135.0 | 42 | 89 |
Black | 73 | 101.8 | ± 50.2 | 120.0 | -2.0 | 172.0 | 99 | 172 |
Hispanic | 57 | 110.7 | ± 36.9 | 118.0 | -2.0 | 160.0 | 59 | 116 |
White | 643 | 101.7 | ± 48.5 | 120.0 | -2.0 | 172.0 | 459 | 1,102 |
Other | 3 | 130.7 | ± 25.5 | 118.0 | 114.0 | 160.0 | 6 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 851 | 121.3 | ± 17.9 | 120.0 | -2.0 | 198.0 | 665 | 1,516 |
Native American | 13 | 121.7 | ± 10.1 | 122.0 | 106.0 | 140.0 | 15 | 28 |
Asian | 50 | 117.9 | ± 9.7 | 118.0 | 98.0 | 142.0 | 39 | 89 |
Black | 75 | 127.4 | ± 14.4 | 125.0 | 102.0 | 198.0 | 97 | 172 |
Hispanic | 61 | 120.2 | ± 19.4 | 118.0 | -1.0 | 160.0 | 55 | 116 |
White | 649 | 120.9 | ± 18.6 | 120.0 | -2.0 | 162.0 | 453 | 1,102 |
Other | 3 | 135.3 | ± 21.4 | 124.0 | 122.0 | 160.0 | 6 | 9 |